跳至主要内容
临床试验/JPRN-UMIN000026254
JPRN-UMIN000026254已完成未知

A Double-Blind, Placebo-Controlled Study for Effects of Daily Oral Administration of "Dattan Soba Seikatsu" on Blood pressure and Blood flow improvement. - Effect of Daily Oral Administration of "Dattan Soba Seikatsu" on Blood pressure and blood flow.

Hokkaido Information University0 个研究点目标入组 46 人开始时间: 2017年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who are under treatment and medication for diabetes and dyslipidemia. 2. Subjects with serious disease and infection. 3. Subjects with clinical history of gastrointestinal surgery. 4. Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. 5. Subjects with serious anemia. 6. Subjects with frequent complaints of post-menopausal symptoms. 7. Subjects with a history of allergy to medicine and food, especially buckwheat and/or gelatin. 8. Subjects regularly take medicine, functional foods and/or supplements which would affect blood pressure and blood flow. 9. Subjects can not stop an intake of medicine, functional foods, supplements, buckwheat and Tartary buckwheat. 10. Subjects who are heavy smokers and alcohol addicts, or subjects with irregular lifestyle. 11. Subjects who donated either 400 ml whole blood within 12 weeks (men) /16 weeks (women) or 200 ml whole blood within 4 weeks or blood components within 2 weeks prior to this study. 12. Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study. 13. Subjects who participate in other clinical trials within the last 4 weeks prior to the current clinical trial. 14. Subjects who are not eligible due to physician's judgment.

研究者

相似试验